H

TuHURA Biosciences Inc
D

HURA

2.45000
USD
-0.01
(-0.41%)
مغلق
حجم التداول
8,999
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
156,022,194
المقالات
المزيد

العنوان: TuHURA Biosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.